Coupled Macroporous Resin Columns for High-Purity Theaflavin Separation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for purifying theaflavins from tea extracts face challenges such as low purity, high cost, cumbersome operation, and high toxicity, making them unsuitable for large-scale production and high-end applications.

Innovation Solution

A method using macroporous resin columns with ethanol and water as eluents, involving two stages of chromatography with specific gradient elutions, to achieve high-purity theaflavins exceeding 95% purity and suitable for large-scale production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional purification methods (high-speed counter-current chromatography, gel chromatography, silica gel chromatography) are used, then theaflavin separation is achieved, but the process becomes cumbersome, costly, and uses toxic organic reagents

Engineering Contradiction:
Improvetheaflavin purityVSAvoidoperation simplicity
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The patent changes the fundamental parameter of the purification medium from toxic organic reagents to safe water and ethanol solutions. By adjusting the polarity parameters of the eluent system, the method achieves effective separation of theaflavins from catechins and other impurities while eliminating toxicity and simplifying operations. The gradient elution using varying concentrations of ethanol in water provides controlled separation without complex equipment.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs macroporous resin columns that are inexpensive, easily replaceable, and can be regenerated. These resin columns serve as the separation medium and can be disposed of or regenerated at low cost, eliminating the need for expensive, complex chromatography systems and toxic reagents that require special handling and disposal procedures.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Object-affected harmful factors

If macroporous resin is used for theaflavin purification, then cost and safety are improved, but the purity increase is limited (from 15%-30% to 44.1%-90.8%)

Engineering Contradiction:
Improvetoxicity and costVSAvoidtheaflavin purity
Core Design Contradiction:
Object-affected harmful factorsVSManufacturing precision

Solution Approach 1:

The patent divides the purification process into multiple sequential stages using different macroporous resin columns with specific pore sizes and chemical properties. The first stage uses resin with larger pores for initial separation, followed by resin with smaller pores for finer separation. This segmentation allows progressive purification, achieving 95% or higher purity while maintaining the advantages of low cost and safety throughout the process.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs composite macroporous resin materials with specific combinations of pore structure, surface chemistry, and hydrophobicity. By selecting resins with complementary properties for different purification stages, the system achieves synergistic effects that dramatically increase purity while maintaining the inherent safety and cost-effectiveness of macroporous resin materials.

Inventive Principle:
Principle #40Composite materials

3Ease of operation

If existing macroporous resin methods are used, then the process is simplified and safe, but the yield and recovery rate are insufficient for large-scale production

Engineering Contradiction:
Improveprocess simplicityVSAvoidtheaflavin yield and recovery rate
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The patent implements continuous gradient elution processes where the eluent composition is continuously adjusted to optimize theaflavin recovery. Multiple resin columns operate in sequence, with each column receiving the effluent from the previous one, creating a continuous purification stream that maximizes yield while maintaining operational simplicity and safety throughout the entire process.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high-purity theaflavins with a yield of over 80% and a total recovery rate of 95% or more, addressing the limitations of existing technologies by being cost-effective, safe, and scalable.

Implementation Method 1

the primary sample solution is loaded onto a resin column to enable theaflavins to be adsorbed on resin

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

gradient elution is performed with ethanol solutions at different gradients to obtain a primary purified product

Methodology Applied
Scientific EffectDesorption: Desorption

Implementation Method 3

after being concentrated by rotary evaporation and freeze-dried

Methodology Applied
Scientific EffectEvaporation: Evaporation

Implementation Method 4

after being concentrated by rotary evaporation and freeze-dried

Methodology Applied
Scientific EffectFreezing: Freezing

Data Source

PatentUS20250388557A1Method for Preparing High-purity Theaflavins by Coupling Macroporous Resin Columns
Publication Date: 2025.12.25 JIANGNAN UNIV
  • US20250388557A1 patent drawing
  • US20250388557A1 patent drawing

AI summary

Disclosed is a method for preparing high-purity theaflavins by coupling macroporous resin columns, belonging to the technical field of food engineering. A crude theaflavin solution with a purity of 15%-30% is loaded onto an LX-20B resin column and subjected to gradient elution according to a specific procedure; eluent is concentrated by rotary evaporation and/or freeze-dried to obtain a primary purified product; a solution of the primary purified product is loaded onto an AB-8 resin column and subjected to gradient elution according to the specific procedure; and eluent is concentrated by rotary evaporation and freeze-dried to obtain a high-purity theaflavins product with a purity of 95% or more, which can meet demands for high-purity theaflavins in some high-end health products and pharmaceutical research and development fields, and thus broadens an application range of theaflavins.